The biotechnology sector in Türkiye has shown significant growth in patent filings over the past decade. From 2013 to 2023, the number of patents increased remarkably from 13.75 to 191.2 units. The sector experienced fluctuating but overall positive year-on-year variations, peaking in 2022 with a noticeable increase of 37.74% and a Compound Annual Growth Rate (CAGR) of 30.8% over the last five years.
Looking forward, the forecasted data from 2024 to 2028 projects continued growth, albeit at a slower pace. The number of patents is expected to rise from 226.08 to 363.85 units, with a forecasted five-year CAGR of 9.98%, indicative of a cumulative growth rate of 60.94%. This suggests a steady but decelerating growth pattern in patent filings within the sector.
- The year 2023 stood at 191.2 units.
- From 2021 to 2023, notable increases were seen with year-on-year variations of 59.07%, 37.74%, and 27.55% respectively.
- Historical CAGR over the last decade showed strong growth, often surpassing 30% yearly.
- The forecast suggests a moderated growth rate but a continued upward trajectory in patent activities up to 2028.
Future trends to watch for include potential technological breakthroughs, increased funding, government policies supportive of innovation, and global collaborations, which could drive the next wave of growth in the biotechnology patent landscape in Türkiye.
